Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-21

FDA Approved: SUMATRIPTAN SUCCINATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical's sumatriptan succinate as an original ANDA, granting generic approval for this migraine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan succinate (Sumatriptan succinate)

Snippet

ORIG AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)